转移性骨折的内部:分子基础和新的潜在治疗点
Alessandro Bruschi1,2, Andrea Sambri1, Michele Fiore1,3
1Orthopedic and Traumatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Cancer medicine
|April 30, 2025
概括
预测骨转移并发症 (如骨折) 是一个挑战. 这项研究探讨了分子生物标志物和潜在的药物标,以改善骨转移癌症患者的诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物 生物标志物
背景情况:
- 骨转移显著影响癌症患者的预后和生活质量.
- 目前的临床和放射学方法不足以预测骨相关事件 (SREs).
研究的目的:
- 调查关键分子参与骨转移和完整性破坏的关键分子参与者.
- 为了确定预测SREs的潜在生物标志物.
主要方法:
- 专注于分子通路,包括矩阵金属蛋白酶 (MMPs),整体蛋白,骨形态遗传蛋白 (BMPs) 和帕拉荷尔蒙相关蛋白 (PTHrP).
- 探索RANK/RANKL/骨质保护素 (OPG) 途径和N端 (NTx) 的研究.
- 对针对这些分子通路的治疗剂的审查.
主要成果:
- 被研究的分子水平升高是潜在的SRE预测因素,但需要进一步研究.
- 针对MMP,整蛋白,BMP和PTHrP的各种药物在对抗这些分子方面表现有前途.
- 这些药物在预防和治疗转移性骨折方面的有效性尚未得到评估.
结论:
- 先进的分子生物学和转录学对于识别骨转移中的新型治疗点至关重要.
- 使用人工智能将分子生物标志物与临床/放射学数据相结合,可以提高诊断和治疗策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Fractures: Bone Repair
2.8K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.8K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K


